Abstract | AIMS: METHODS: A masked, prospective, controlled trial was conducted over a 2 year period in a Kenyan hospital. Randomisation was achieved by alternating weeks of one or two eye drop application to both eyes. All 719 neonates received one drop of the povidone-iodine solution to both eyes at birth, while 317 received a second drop at hospital discharge or 24 (SD 4) hours after delivery, whichever was first. All infants developing conjunctivitis within a month after birth underwent microbiological analysis using Gram and Giemsa stains, direct fluorescent antibody assay for Chlamydia trachomatis, and culture. RESULTS: Of the neonates receiving the one eye drop application, 18.4% returned with a red eye with discharge, 4.0% had organisms found on the initial smear, and 8.2% had a positive culture. The corresponding proportions for the multidrop group were 24.3%, 4.7%, and 10.4%. Of those returning with an inflamed eye, there were no cases of Neisseria gonorrhoeae, 4.2% in the single dose group and 3.9% in the double dose group were positive for C trachomatis, and 5.4% and 6.5% respectively for Staphylococcus aureus. At discharge, the eyelid oedema score of the double dose group was mildly greater than the single dose group (1.4 (0.67) v 1.2 (0.73), p=0.0002). There was no statistically significant difference between the groups in any other category. CONCLUSION:
|
Authors | S J Isenberg, L Apt, M Del Signore, S Gichuhi, N G Berman |
Journal | The British journal of ophthalmology
(Br J Ophthalmol)
Vol. 87
Issue 12
Pg. 1449-52
(Dec 2003)
ISSN: 0007-1161 [Print] England |
PMID | 14660449
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Infective Agents, Local
- Ophthalmic Solutions
- Povidone-Iodine
|
Topics |
- Anti-Infective Agents, Local
(administration & dosage, adverse effects)
- Chlamydia Infections
(diagnosis)
- Developing Countries
- Drug Administration Schedule
- Edema
(chemically induced)
- Eyelid Diseases
(chemically induced)
- Female
- Fluorescent Antibody Technique, Direct
- Humans
- Infant, Newborn
- Kenya
- Male
- Ophthalmia Neonatorum
(prevention & control)
- Ophthalmic Solutions
- Povidone-Iodine
(administration & dosage, adverse effects)
- Prospective Studies
|